PL2398818T3 - Środki do oczyszczania białka z osocza krwi i sposoby ich realizacji - Google Patents

Środki do oczyszczania białka z osocza krwi i sposoby ich realizacji

Info

Publication number
PL2398818T3
PL2398818T3 PL10709893T PL10709893T PL2398818T3 PL 2398818 T3 PL2398818 T3 PL 2398818T3 PL 10709893 T PL10709893 T PL 10709893T PL 10709893 T PL10709893 T PL 10709893T PL 2398818 T3 PL2398818 T3 PL 2398818T3
Authority
PL
Poland
Prior art keywords
purifying
protein
methods
blood plasma
implementing same
Prior art date
Application number
PL10709893T
Other languages
English (en)
Inventor
Gérald PERRET
Michel Nogre
Original Assignee
Laboratoire Français Du Fractionnement Et Des Biotechnologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Français Du Fractionnement Et Des Biotechnologies filed Critical Laboratoire Français Du Fractionnement Et Des Biotechnologies
Publication of PL2398818T3 publication Critical patent/PL2398818T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/647Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/16Aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL10709893T 2009-02-19 2010-02-19 Środki do oczyszczania białka z osocza krwi i sposoby ich realizacji PL2398818T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0951083A FR2942233B1 (fr) 2009-02-19 2009-02-19 Moyens pour la purification d'une proteine du plasma sanguin, et procedes pour sa mise en oeuvre
PCT/FR2010/050294 WO2010094901A1 (fr) 2009-02-19 2010-02-19 Moyens pour la purification d'une proteine du plasma sanguin, et procedes pour sa mise en œuvre
EP10709893.1A EP2398818B1 (fr) 2009-02-19 2010-02-19 Moyens pour la purification d'une proteine du plasma sanguin, et procedes pour sa mise en oeuvre

Publications (1)

Publication Number Publication Date
PL2398818T3 true PL2398818T3 (pl) 2019-02-28

Family

ID=41319742

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10709893T PL2398818T3 (pl) 2009-02-19 2010-02-19 Środki do oczyszczania białka z osocza krwi i sposoby ich realizacji

Country Status (14)

Country Link
US (1) US9534012B2 (pl)
EP (1) EP2398818B1 (pl)
JP (2) JP6129473B2 (pl)
KR (1) KR101713761B1 (pl)
CN (1) CN102405228B (pl)
AU (1) AU2010215304B2 (pl)
BR (1) BRPI1008044A8 (pl)
CA (1) CA2753172A1 (pl)
DK (1) DK2398818T3 (pl)
ES (1) ES2700225T3 (pl)
FR (1) FR2942233B1 (pl)
IL (1) IL214567A (pl)
PL (1) PL2398818T3 (pl)
WO (1) WO2010094901A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948665B1 (fr) 2009-07-31 2011-09-23 Lfb Biotechnologies Procede pour la purification de proteines de la coagulation a domaine gla actives
FR2948664B1 (fr) * 2009-07-31 2013-11-01 Lfb Biotechnologies Procede pour la purification de proteines de la coagulation a domaine gla
FR2983212A1 (fr) * 2011-11-28 2013-05-31 Lfb Biotechnologies Aptameres anti-fh, procede pour leur obtention et utilisations
EP2687595B1 (en) 2012-07-19 2018-05-30 Laboratoire Français du Fractionnement et des Biotechnologies Method for purifying transgenic factor VII
CN112717125A (zh) * 2012-10-03 2021-04-30 瑞士杰特贝林生物制品有限公司 一种纯化蛋白质的方法
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
WO2014113712A1 (en) 2013-01-20 2014-07-24 Dyax Corp. Evaluation and treatment of bradykinin-mediated disorders
ES2894837T3 (es) 2013-04-18 2022-02-16 Inst Nat Sante Rech Med Composición con inmunogenicidad reducida
EP2821076A1 (en) 2013-07-02 2015-01-07 Stallergenes Sa C1q as a therapeutic agent of allergy and/or asthma
PL3060582T3 (pl) 2013-10-21 2021-05-04 Dyax Corp. Testy do oznaczania biomarkerów układu kalikreiny osoczowej
WO2015066080A2 (en) * 2013-10-28 2015-05-07 The Regents Of The University Of California Lipid co-factor essential for cell density signaling
FR3018450B1 (fr) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
EP2974741A1 (en) 2014-07-16 2016-01-20 Stallergenes Composition of allergen extracts having reduced toxicity and method of production thereof
EP3613764A1 (en) 2014-10-15 2020-02-26 Xenothera Composition with reduced immunogenicity
GB201506113D0 (en) 2015-04-10 2015-05-27 Ge Healthcare Bio Sciences Ab Method for chromatography
GB201506117D0 (en) 2015-04-10 2015-05-27 Ge Healthcare Bio Sciences Ab Method for chromatography
ES2857552T3 (es) 2015-10-19 2021-09-29 Takeda Pharmaceuticals Co Inmunoensayo para detectar cininógenos de alto peso molecular escindido
EP3491136A1 (en) * 2016-07-28 2019-06-05 Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme Anti- immunoglobulin g aptamers and uses thereof
CN106148465B (zh) * 2016-08-09 2020-02-14 广东海洋大学 一种具有抗氧化活性的鲎血浆蛋白水解肽及其制备方法和应用
CA3115393A1 (en) * 2018-10-17 2020-04-23 Csl Behring Gmbh Process for purifying c1-inh
EP3962957A1 (en) 2019-04-30 2022-03-09 Xenothera Association of polyclonal antibodies and anti-pd1 or anti-pdl1 antibodies for the treatment of cancer
GB201906595D0 (en) * 2019-05-10 2019-06-26 Ge Healthcare Bioprocess R&D Ab Method for purification of plasma proteins
CN111000974B (zh) * 2020-02-24 2021-07-27 重庆大学 一种兔奶活性小肽溶液及其提取方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JP2869417B2 (ja) * 1992-09-22 1999-03-10 吉富製薬株式会社 遺伝子操作により得られるヒト血清アルブミン
JP3508149B2 (ja) * 1993-02-25 2004-03-22 三菱ウェルファーマ株式会社 ヒト血清アルブミンおよびその製造方法
US5440018A (en) 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
CA2116385A1 (en) 1993-02-25 1994-08-26 Akinori Sumi Human serum albumin and process for producing the same
US6117996A (en) * 1995-09-20 2000-09-12 Novo Nordisk A/S Triazine based ligands and use thereof
EP1330544A4 (en) * 2000-09-26 2005-04-06 Univ Duke RNA APTAMERS AND METHOD OF IDENTIFYING SAID APTAMERS
EP1786273B1 (en) * 2004-08-20 2018-11-14 ProMetic BioSciences Ltd. Sequential protein isolation and purification schemes by affinity chromatography
US8367627B2 (en) * 2005-09-15 2013-02-05 Duke University Focused libraries, functional profiling, laser SELEX, and DESELEX
WO2007058592A1 (en) * 2005-11-21 2007-05-24 Ge Healthcare Bio-Sciences Ab A method of chromatography using semi-synthetic heparin ligands
FR2910786B1 (fr) * 2006-12-29 2017-08-11 Laboratoire Francais Du Fractionnement Et Des Biotechnologies (Lfb) "procede d'extraction d'une proteine presente dans du lait"

Also Published As

Publication number Publication date
BRPI1008044A2 (pt) 2016-05-03
JP2012518033A (ja) 2012-08-09
JP2016028027A (ja) 2016-02-25
AU2010215304B2 (en) 2015-08-13
BRPI1008044A8 (pt) 2018-04-03
ES2700225T3 (es) 2019-02-14
EP2398818A1 (fr) 2011-12-28
FR2942233B1 (fr) 2015-03-13
IL214567A (en) 2016-12-29
CN102405228A (zh) 2012-04-04
FR2942233A1 (fr) 2010-08-20
JP6129473B2 (ja) 2017-05-17
CA2753172A1 (fr) 2010-08-26
KR20110139199A (ko) 2011-12-28
WO2010094901A1 (fr) 2010-08-26
CN102405228B (zh) 2016-08-24
US20120122179A1 (en) 2012-05-17
EP2398818B1 (fr) 2018-08-29
US9534012B2 (en) 2017-01-03
AU2010215304A1 (en) 2011-09-08
IL214567A0 (en) 2011-09-27
KR101713761B1 (ko) 2017-03-08
DK2398818T3 (da) 2019-01-02

Similar Documents

Publication Publication Date Title
IL214567A0 (en) Means for purifying a protein of blood plasma and methods for implementing same
IL261147A (en) Methods for purification of polypeptides
ZA201301455B (en) Devices and methods for filtering blood plasma
EP2513142A4 (en) MEMBRANES AND APPROPRIATE PROCEDURES FOR CLEANING ANTIBODIES
IL225650A0 (en) Protein purification processes
ZA201209048B (en) Apparatus and process of purification of proteins
IL215082A0 (en) Methods of purifying small modular immunopharmaceutical proteins
HK1168815A1 (en) System and method for the re-anticoagulation of platelet rich plasma
ZA201202274B (en) Gas purification configurations and method
EP3715356C0 (en) PROCESS FOR PURIFYING POLYPEPTIDES
EP2535067A4 (en) BLOOD PURIFICATION DEVICE AND PRIMING METHOD THEREOF
EP2396399A4 (en) SYSTEMS AND METHOD FOR PURIFYING BIOLOGICAL MATERIALS
EP2473272A4 (en) Systems and methods for gas treatment
EP2411122A4 (en) METHOD FOR SEPARATING GASES
SI2598516T1 (sl) Postopek za čiščenje proteinov
IL220190A0 (en) Proteasome inhibitors and processes for their preparation, purification and use
IL214566A0 (en) Means for purifying a coagulation protein, and methods for implementing same
PL2255838T3 (pl) Sposób i urządzenie do podziału krwi pełnej
IL219348A0 (en) Method for purification of colistin and purified colistin components
EP2519537A4 (en) CLEANING PROTEINS
EP2351588A4 (en) PLASMA CLEANING DEVICE AND METHOD FOR CONTROLLING A BLOOD CLEANING DEVICE
EP2617444A4 (en) BLOOD PURIFICATION DEVICE AND CONTROL METHOD THEREOF
EP2488228A4 (en) Method and product for blood treatment and purification
ZA201200420B (en) Method for the purification of protein complexes
EP2301950A4 (en) SEPARATION AGENT FOR PURIFYING PROTEIN AND METHOD FOR PURIFYING PROTEIN